Clinical Laboratory Improvement Amendments of 1988 (CLIA) CMS Location and State Agency Updates to COVID-19 Survey Prioritization Guidance

CMS remains committed to taking critical steps to ensure America’s clinical laboratories are in compliance with the CLIA regulations amid the public health emergency (PHE) caused by Coronavirus Disease 2019 (COVID-19). • CMS is issuing this memorandum to CLIA State Agencies to provide updated guidance on actions to fully resume CLIA survey activities. These steps include: o Guidance for on-site surveys o Guidance for enforcement actions and PT review.